Bioinfinty definitely stand behind their product. Have resolved any questions I've had. Product delivery is second to none. Very quick turnaround. Highly recommend using Bioinfinity.
Selank — clinical & mechanistic profile
Selank is a synthetic heptapeptide analog of tuftsin with additional glyproline residues, developed in Russia and investigated for anxiolytic, neuropeptide-signalling, neuroprotective, and immunomodulatory effects through GABAergic and neurotransmitter system modulation.
Research status
mixed
Sequence
Thr-Lys-Pro-Arg-Pro-Gly-Pro
Molecular weight
751.88 g/mol
Molecular formula
C33H57N11O9
Studied applications
- •Anxiolytic effects: demonstrates activity comparable to low-dose benzodiazepines without sedation or dependence
- •GABAergic modulation: allosterically affects GABA-A receptors, increasing GABA binding affinity
- •Neuropeptide-Signalling research: studied for neuropeptide signalling, memory, and attention effects
- •Immunomodulation: influences IL-6 expression, T helper cell balance, and enkephalin stabilization as tuftsin analog
- •BDNF elevation: rapidly increases brain-derived neurotrophic factor in hippocampus
Mechanisms of action
- •GABA-A receptor allosteric modulation: increases GABA binding affinity, mimicking benzodiazepine-like actions without side effects
- •Enkephalin system: inhibits enkephalin-degrading enzymes, increasing leu-enkephalin half-life
- •Serotonin/dopamine modulation: affects monoaminergic neurotransmission in mood and anxiety circuits
- •BDNF upregulation: rapidly elevates brain-derived neurotrophic factor for neuronal health
- •Hypocretin gene expression: normalizes sleep-wake balance through Hcrt gene modulation
- •Tuftsin receptor interaction: modulates immune function through tuftsin pathway activation
- •Approved only in Russia—not FDA approved or available by prescription in Western countries
- •Limited Western clinical data—most research from Russian institutions
- •Intranasal administration primarily studied—other routes less characterized
- •Long-term safety data limited even in approved jurisdiction
- •Independent replication of findings in Western laboratories is sparse
Peer-reviewed references
- Uchakina ON, et al. — Selank immunomodulatory mechanismsPMID: 19515342View
- Semenova TP, et al. — Selank GABA system interactions (2017)PMID: 28643444View
- Zozulia AA, et al. — Selank clinical anxiolytic studiesPMID: 18454096View
- Selank effects on neurotransmitter systemsPMID: 27403905View
- Selank positive allosteric modulation of GABA_A receptorsPMID: 30255741View
For research use only. This summary is a research-scientific overview compiled from peer-reviewed sources. It is not medical advice and is not intended for human or veterinary consumption.
Related products

